HIV prevention drug hailed as breakthrough, but who gets access?
Lenacapavir, a twice-a-year injection could transform HIV prevention, but it will not be available to all.

Lenacapavir, a twice-a-year injection could transform HIV prevention, but it will not be available to all.






![Pope Leo XIV waves to the crowd as he leaves at the end of a prayer vigil with young people at the Stade de France stadium, in Saint-Denis on the outskirts of Paris. [AFP]](https://aljazeeranews.edgeone.app/wp-content/uploads/2026/09/afp_6ab6f342b1d9-1790374722.jpg?resize=770%2C513&quality=80)

Xi says China and US have a relationship of ‘strategic stability’ during three-day state visit to Washington, DC.
Warmth on display in Washington contrasts significantly with the language Trump has used to characterise Beijing and Xi.
Some analysts say extending the truce is pure optics – others say it’s a useful step towards a more durable deal.

Pervasive, persistent and poisonous: How one US company helped pollute the world with forever chemicals.
Incident highlights growing concerns about AI’s impact on cybersecurity and AI disclosure procedures, say experts.
The US dominates AI spending and computing power, but China is ahead in research and closing the gap on advanced models.
AI giant announces discovery amid global debate about how to safeguard against catastrophic risks.
Canberra expressed extreme concern to Sam Altman after OpenAI took three months to report the breach.
In this episode of On the Record, UN Secretary-General António Guterres calls for ban on autonomous ‘killer robots’.